title: [Secondary prevention of ischemic stroke: aspirin or ticlopidine].
authors.forename: J L
authors.initials: JL
authors.lastname: Zambrana
authors.forename: F
authors.initials: F
authors.lastname: Díez
authors.forename: M
authors.initials: M
authors.lastname: Delgado
authors.forename: J
authors.initials: J
authors.lastname: Salas
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012306:Risk; D013988:Ticlopidine / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin
vernacular_title: Prevención secundaria de los ictus isquémicos: aspirina o ticlopidina?